Stocks and InvestingStocks and Investing
Wed, April 26, 2023
Tue, April 25, 2023

Andreas Argyrides Maintained (UBX) at Buy with Decreased Target to $3 on, Apr 25th, 2023


Published on 2024-10-28 03:00:29 - WOPRAI, Andreas Argyrides
  Print publication without navigation


Andreas Argyrides of Wedbush, Maintained "Unity Biotechnology, Inc." (UBX) at Buy with Decreased Target from $5 to $3 on, Apr 25th, 2023.

Andreas has made no other calls on UBX in the last 4 months.



There are 4 other peers that have a rating on UBX. Out of the 4 peers that are also analyzing UBX, 0 agree with Andreas's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Andreas


  • Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Tuesday, March 28th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, March 28th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, March 28th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023